Combining ultrasound imaging with blood tests can increase liver cancer detection by 40%

Using ultrasound imaging along with a blood test significantly improves detection of early-stage liver cancer, according to research published in Gastroenterology.

Advertisement

The research is a meta-analysis of 32 previous studies. Researchers found combining ultrasound imaging with a blood test for high alpha fetoprotein levels can increase early-stage liver cancer detection by up to 40 percent. Alpha fetoprotein, a plasma protein, is low in adults, but liver cancer causes alpha fetoprotein levels to increase.

“If the cancer is found early, then we can perform curative therapies, allowing patients to live many years,” said G. Amit Singal, MD, associate professor of internal medicine and clinical sciences with UT Southwestern Harold C. Simmons Comprehensive Cancer Center in Dallas.

The Simmons Cancer Center is one of only 49 National Cancer Institute-designated Comprehensive Cancer Centers in the nation.

More articles on healthcare quality:
University Hospitals nurse fired for calling in sick with flu: 4 things to know
Flu-related hospitalizations reach 10-year high: 4 things to know
Why this flu season is especially bad for baby boomers

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The 2 KPIs that drive readmissions — and how hospitals act on them in real time

Tuesday, August 11
1:00 PM - 2:00 PM CDT

Presenter: Nik Rao, Dexur

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.